HashiCorp, Inc.
HashiCorp, Inc. (HCP) Stock Competitors & Peer Comparison
See (HCP) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Infrastructure Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HCP | $34.78 | +0.00% | 7.1B | -57.97 | -$0.60 | N/A |
| MSFT | $412.66 | -0.59% | 3.1T | 24.61 | $16.77 | +0.85% |
| ORCL | $193.84 | -1.08% | 557.5B | 34.86 | $5.56 | +1.03% |
| PLTR | $136.89 | -0.66% | 314.3B | 152.10 | $0.90 | N/A |
| PANW | $213.66 | +2.78% | 145.7B | 118.08 | $1.81 | N/A |
| CRWD | $542.26 | +2.75% | 137.5B | -860.73 | -$0.63 | N/A |
| ADBE | $246.15 | -2.72% | 99.5B | 14.34 | $17.16 | N/A |
| SNPS | $516.19 | -0.06% | 98.9B | 79.29 | $6.51 | N/A |
| FTNT | $115.44 | +1.20% | 85.4B | 44.74 | $2.58 | N/A |
| NET | $193.52 | -1.33% | 68.3B | -773.64 | -$0.25 | N/A |
Stock Comparison
HCP vs MSFT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, MSFT has a market cap of 3.1T. Regarding current trading prices, HCP is priced at $34.78, while MSFT trades at $412.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas MSFT's P/E ratio is 24.61. In terms of profitability, HCP's ROE is -0.16%, compared to MSFT's ROE of +0.33%. Regarding short-term risk, HCP is less volatile compared to MSFT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MSFT's competition here
HCP vs ORCL Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ORCL has a market cap of 557.5B. Regarding current trading prices, HCP is priced at $34.78, while ORCL trades at $193.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ORCL's P/E ratio is 34.86. In terms of profitability, HCP's ROE is -0.16%, compared to ORCL's ROE of +0.57%. Regarding short-term risk, HCP is less volatile compared to ORCL. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ORCL's competition here
HCP vs PLTR Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PLTR has a market cap of 314.3B. Regarding current trading prices, HCP is priced at $34.78, while PLTR trades at $136.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PLTR's P/E ratio is 152.10. In terms of profitability, HCP's ROE is -0.16%, compared to PLTR's ROE of +0.32%. Regarding short-term risk, HCP is less volatile compared to PLTR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PLTR's competition here
HCP vs PANW Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PANW has a market cap of 145.7B. Regarding current trading prices, HCP is priced at $34.78, while PANW trades at $213.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PANW's P/E ratio is 118.08. In terms of profitability, HCP's ROE is -0.16%, compared to PANW's ROE of +0.15%. Regarding short-term risk, HCP is less volatile compared to PANW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PANW's competition here
HCP vs CRWD Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CRWD has a market cap of 137.5B. Regarding current trading prices, HCP is priced at $34.78, while CRWD trades at $542.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CRWD's P/E ratio is -860.73. In terms of profitability, HCP's ROE is -0.16%, compared to CRWD's ROE of -0.05%. Regarding short-term risk, HCP is less volatile compared to CRWD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CRWD's competition here
HCP vs ADBE Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ADBE has a market cap of 99.5B. Regarding current trading prices, HCP is priced at $34.78, while ADBE trades at $246.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ADBE's P/E ratio is 14.34. In terms of profitability, HCP's ROE is -0.16%, compared to ADBE's ROE of +0.62%. Regarding short-term risk, HCP is less volatile compared to ADBE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ADBE's competition here
HCP vs SNPS Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SNPS has a market cap of 98.9B. Regarding current trading prices, HCP is priced at $34.78, while SNPS trades at $516.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SNPS's P/E ratio is 79.29. In terms of profitability, HCP's ROE is -0.16%, compared to SNPS's ROE of +0.05%. Regarding short-term risk, HCP is less volatile compared to SNPS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SNPS's competition here
HCP vs FTNT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FTNT has a market cap of 85.4B. Regarding current trading prices, HCP is priced at $34.78, while FTNT trades at $115.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FTNT's P/E ratio is 44.74. In terms of profitability, HCP's ROE is -0.16%, compared to FTNT's ROE of +1.56%. Regarding short-term risk, HCP is less volatile compared to FTNT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FTNT's competition here
HCP vs NET Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NET has a market cap of 68.3B. Regarding current trading prices, HCP is priced at $34.78, while NET trades at $193.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NET's P/E ratio is -773.64. In terms of profitability, HCP's ROE is -0.16%, compared to NET's ROE of -0.06%. Regarding short-term risk, HCP is less volatile compared to NET. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NET's competition here
HCP vs VMW Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, HCP is priced at $34.78, while VMW trades at $142.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas VMW's P/E ratio is 42.92. In terms of profitability, HCP's ROE is -0.16%, compared to VMW's ROE of +3.99%. Regarding short-term risk, HCP is less volatile compared to VMW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VMW's competition here
HCP vs CRWV Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CRWV has a market cap of 60.6B. Regarding current trading prices, HCP is priced at $34.78, while CRWV trades at $114.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CRWV's P/E ratio is -42.17. In terms of profitability, HCP's ROE is -0.16%, compared to CRWV's ROE of -0.40%. Regarding short-term risk, HCP is less volatile compared to CRWV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CRWV's competition here
HCP vs SQ Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, HCP is priced at $34.78, while SQ trades at $83.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SQ's P/E ratio is 49.98. In terms of profitability, HCP's ROE is -0.16%, compared to SQ's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to SQ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SQ's competition here
HCP vs XYZ Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, XYZ has a market cap of 43.6B. Regarding current trading prices, HCP is priced at $34.78, while XYZ trades at $73.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas XYZ's P/E ratio is 57.17. In terms of profitability, HCP's ROE is -0.16%, compared to XYZ's ROE of +0.04%. Regarding short-term risk, HCP is less volatile compared to XYZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check XYZ's competition here
HCP vs NETE Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, HCP is priced at $34.78, while NETE trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NETE's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to NETE's ROE of +3.34%. Regarding short-term risk, HCP is less volatile compared to NETE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NETE's competition here
HCP vs SPLK Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, HCP is priced at $34.78, while SPLK trades at $156.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SPLK's P/E ratio is 103.22. In terms of profitability, HCP's ROE is -0.16%, compared to SPLK's ROE of +0.84%. Regarding short-term risk, HCP is more volatile compared to SPLK. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SPLK's competition here
HCP vs VRSN Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, VRSN has a market cap of 26.1B. Regarding current trading prices, HCP is priced at $34.78, while VRSN trades at $286.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas VRSN's P/E ratio is 31.65. In terms of profitability, HCP's ROE is -0.16%, compared to VRSN's ROE of -0.40%. Regarding short-term risk, HCP is less volatile compared to VRSN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VRSN's competition here
HCP vs ZS Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ZS has a market cap of 23.9B. Regarding current trading prices, HCP is priced at $34.78, while ZS trades at $148.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ZS's P/E ratio is -346.21. In terms of profitability, HCP's ROE is -0.16%, compared to ZS's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to ZS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ZS's competition here
HCP vs MDB Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, MDB has a market cap of 23.7B. Regarding current trading prices, HCP is priced at $34.78, while MDB trades at $294.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas MDB's P/E ratio is -338.68. In terms of profitability, HCP's ROE is -0.16%, compared to MDB's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to MDB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MDB's competition here
HCP vs CPAY Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CPAY has a market cap of 22.6B. Regarding current trading prices, HCP is priced at $34.78, while CPAY trades at $341.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CPAY's P/E ratio is 20.49. In terms of profitability, HCP's ROE is -0.16%, compared to CPAY's ROE of +0.31%. Regarding short-term risk, HCP is less volatile compared to CPAY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CPAY's competition here
HCP vs AKAM Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, AKAM has a market cap of 22.5B. Regarding current trading prices, HCP is priced at $34.78, while AKAM trades at $153.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas AKAM's P/E ratio is 51.87. In terms of profitability, HCP's ROE is -0.16%, compared to AKAM's ROE of +0.09%. Regarding short-term risk, HCP is less volatile compared to AKAM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AKAM's competition here
HCP vs AFRM Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, AFRM has a market cap of 22.3B. Regarding current trading prices, HCP is priced at $34.78, while AFRM trades at $66.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas AFRM's P/E ratio is 60.41. In terms of profitability, HCP's ROE is -0.16%, compared to AFRM's ROE of +0.11%. Regarding short-term risk, HCP is less volatile compared to AFRM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AFRM's competition here
HCP vs FLT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, HCP is priced at $34.78, while FLT trades at $303.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FLT's P/E ratio is 22.97. In terms of profitability, HCP's ROE is -0.16%, compared to FLT's ROE of +0.31%. Regarding short-term risk, HCP is less volatile compared to FLT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FLT's competition here
HCP vs CYBR Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CYBR has a market cap of 20.6B. Regarding current trading prices, HCP is priced at $34.78, while CYBR trades at $408.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CYBR's P/E ratio is -139.06. In terms of profitability, HCP's ROE is -0.16%, compared to CYBR's ROE of -0.06%. Regarding short-term risk, HCP is more volatile compared to CYBR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check CYBR's competition here
HCP vs FFIV Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FFIV has a market cap of 20.2B. Regarding current trading prices, HCP is priced at $34.78, while FFIV trades at $358.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FFIV's P/E ratio is 29.42. In terms of profitability, HCP's ROE is -0.16%, compared to FFIV's ROE of +0.20%. Regarding short-term risk, HCP is less volatile compared to FFIV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FFIV's competition here
HCP vs DOCN Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, DOCN has a market cap of 17B. Regarding current trading prices, HCP is priced at $34.78, while DOCN trades at $162.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas DOCN's P/E ratio is 71.36. In terms of profitability, HCP's ROE is -0.16%, compared to DOCN's ROE of +1.66%. Regarding short-term risk, HCP is less volatile compared to DOCN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DOCN's competition here
HCP vs IOT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, IOT has a market cap of 16.7B. Regarding current trading prices, HCP is priced at $34.78, while IOT trades at $29.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas IOT's P/E ratio is -1453.00. In terms of profitability, HCP's ROE is -0.16%, compared to IOT's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to IOT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check IOT's competition here
HCP vs KSPI Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, KSPI has a market cap of 16.3B. Regarding current trading prices, HCP is priced at $34.78, while KSPI trades at $85.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas KSPI's P/E ratio is 7.15. In terms of profitability, HCP's ROE is -0.16%, compared to KSPI's ROE of +0.50%. Regarding short-term risk, HCP is less volatile compared to KSPI. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KSPI's competition here
HCP vs NLOK Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, HCP is priced at $34.78, while NLOK trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NLOK's P/E ratio is 15.15. In terms of profitability, HCP's ROE is -0.16%, compared to NLOK's ROE of +0.40%. Regarding short-term risk, HCP is less volatile compared to NLOK. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NLOK's competition here
HCP vs TOST Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, TOST has a market cap of 14B. Regarding current trading prices, HCP is priced at $34.78, while TOST trades at $24.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas TOST's P/E ratio is 36.10. In terms of profitability, HCP's ROE is -0.16%, compared to TOST's ROE of +0.21%. Regarding short-term risk, HCP is less volatile compared to TOST. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TOST's competition here
HCP vs OKTA Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, OKTA has a market cap of 13.8B. Regarding current trading prices, HCP is priced at $34.78, while OKTA trades at $81.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas OKTA's P/E ratio is 62.36. In terms of profitability, HCP's ROE is -0.16%, compared to OKTA's ROE of +0.03%. Regarding short-term risk, HCP is less volatile compared to OKTA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check OKTA's competition here
HCP vs GEN Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GEN has a market cap of 13.6B. Regarding current trading prices, HCP is priced at $34.78, while GEN trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GEN's P/E ratio is 14.27. In terms of profitability, HCP's ROE is -0.16%, compared to GEN's ROE of +0.40%. Regarding short-term risk, HCP is less volatile compared to GEN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GEN's competition here
HCP vs PAYP Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PAYP has a market cap of 12.8B. Regarding current trading prices, HCP is priced at $34.78, while PAYP trades at $19.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PAYP's P/E ratio is 16.85. In terms of profitability, HCP's ROE is -0.16%, compared to PAYP's ROE of +0.58%. Regarding short-term risk, HCP is less volatile compared to PAYP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAYP's competition here
HCP vs RBRK Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, RBRK has a market cap of 12.6B. Regarding current trading prices, HCP is priced at $34.78, while RBRK trades at $62.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas RBRK's P/E ratio is -34.93. In terms of profitability, HCP's ROE is -0.16%, compared to RBRK's ROE of +0.64%. Regarding short-term risk, HCP is less volatile compared to RBRK. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RBRK's competition here
HCP vs CHKP Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CHKP has a market cap of 12B. Regarding current trading prices, HCP is priced at $34.78, while CHKP trades at $115.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CHKP's P/E ratio is 11.87. In terms of profitability, HCP's ROE is -0.16%, compared to CHKP's ROE of +0.36%. Regarding short-term risk, HCP is less volatile compared to CHKP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CHKP's competition here
HCP vs NTNX Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NTNX has a market cap of 12B. Regarding current trading prices, HCP is priced at $34.78, while NTNX trades at $45.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NTNX's P/E ratio is 49.11. In terms of profitability, HCP's ROE is -0.16%, compared to NTNX's ROE of -0.37%. Regarding short-term risk, HCP is less volatile compared to NTNX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NTNX's competition here
HCP vs GDDY Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GDDY has a market cap of 11.7B. Regarding current trading prices, HCP is priced at $34.78, while GDDY trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GDDY's P/E ratio is 13.96. In terms of profitability, HCP's ROE is -0.16%, compared to GDDY's ROE of +3.67%. Regarding short-term risk, HCP is less volatile compared to GDDY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GDDY's competition here
HCP vs CFLT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CFLT has a market cap of 11.1B. Regarding current trading prices, HCP is priced at $34.78, while CFLT trades at $30.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CFLT's P/E ratio is -36.03. In terms of profitability, HCP's ROE is -0.16%, compared to CFLT's ROE of -0.27%. Regarding short-term risk, HCP is more volatile compared to CFLT. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check CFLT's competition here
HCP vs ALTR Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while ALTR trades at $111.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ALTR's P/E ratio is 699.06. In terms of profitability, HCP's ROE is -0.16%, compared to ALTR's ROE of +0.02%. Regarding short-term risk, HCP is more volatile compared to ALTR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check ALTR's competition here
HCP vs PLAN Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while PLAN trades at $63.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PLAN's P/E ratio is -44.82. In terms of profitability, HCP's ROE is -0.16%, compared to PLAN's ROE of -0.78%. Regarding short-term risk, HCP is less volatile compared to PLAN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PLAN's competition here
HCP vs INFA Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, INFA has a market cap of 7.5B. Regarding current trading prices, HCP is priced at $34.78, while INFA trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas INFA's P/E ratio is 826.33. In terms of profitability, HCP's ROE is -0.16%, compared to INFA's ROE of +0.00%. Regarding short-term risk, HCP is more volatile compared to INFA. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check INFA's competition here
HCP vs CORZZ Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZZ has a market cap of 7.3B. Regarding current trading prices, HCP is priced at $34.78, while CORZZ trades at $23.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CORZZ's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to CORZZ's ROE of +1.09%. Regarding short-term risk, HCP is less volatile compared to CORZZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZZ's competition here
HCP vs CORZ Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZ has a market cap of 7.3B. Regarding current trading prices, HCP is priced at $34.78, while CORZ trades at $22.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CORZ's P/E ratio is -6.83. In terms of profitability, HCP's ROE is -0.16%, compared to CORZ's ROE of +1.09%. Regarding short-term risk, HCP is less volatile compared to CORZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZ's competition here
HCP vs JCOM Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, HCP is priced at $34.78, while JCOM trades at $142.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas JCOM's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to JCOM's ROE of +0.06%. Regarding short-term risk, HCP is less volatile compared to JCOM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check JCOM's competition here
HCP vs DBX Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, DBX has a market cap of 6.7B. Regarding current trading prices, HCP is priced at $34.78, while DBX trades at $26.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas DBX's P/E ratio is 14.48. In terms of profitability, HCP's ROE is -0.16%, compared to DBX's ROE of -0.28%. Regarding short-term risk, HCP is less volatile compared to DBX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DBX's competition here
HCP vs DOX Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, DOX has a market cap of 6.7B. Regarding current trading prices, HCP is priced at $34.78, while DOX trades at $62.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas DOX's P/E ratio is 12.10. In terms of profitability, HCP's ROE is -0.16%, compared to DOX's ROE of +0.17%. Regarding short-term risk, HCP is less volatile compared to DOX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DOX's competition here
HCP vs SAIL Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SAIL has a market cap of 6.6B. Regarding current trading prices, HCP is priced at $34.78, while SAIL trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SAIL's P/E ratio is -21.80. In terms of profitability, HCP's ROE is -0.16%, compared to SAIL's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to SAIL. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SAIL's competition here
HCP vs BLSH Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, BLSH has a market cap of 6.6B. Regarding current trading prices, HCP is priced at $34.78, while BLSH trades at $44.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas BLSH's P/E ratio is -7.35. In terms of profitability, HCP's ROE is -0.16%, compared to BLSH's ROE of -0.26%. Regarding short-term risk, HCP is less volatile compared to BLSH. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BLSH's competition here
HCP vs SQSP Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, HCP is priced at $34.78, while SQSP trades at $46.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, HCP's ROE is -0.16%, compared to SQSP's ROE of +0.03%. Regarding short-term risk, HCP is less volatile compared to SQSP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SQSP's competition here
HCP vs NEWR Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, HCP is priced at $34.78, while NEWR trades at $86.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NEWR's P/E ratio is -41.62. In terms of profitability, HCP's ROE is -0.16%, compared to NEWR's ROE of -0.54%. Regarding short-term risk, HCP is more volatile compared to NEWR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check NEWR's competition here
HCP vs PATH Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PATH has a market cap of 5.7B. Regarding current trading prices, HCP is priced at $34.78, while PATH trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PATH's P/E ratio is 20.49. In terms of profitability, HCP's ROE is -0.16%, compared to PATH's ROE of +0.15%. Regarding short-term risk, HCP is less volatile compared to PATH. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PATH's competition here
HCP vs CCCS Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CCCS has a market cap of 5.6B. Regarding current trading prices, HCP is priced at $34.78, while CCCS trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CCCS's P/E ratio is -875.00. In terms of profitability, HCP's ROE is -0.16%, compared to CCCS's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to CCCS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CCCS's competition here
HCP vs S Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, S has a market cap of 5.5B. Regarding current trading prices, HCP is priced at $34.78, while S trades at $16.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas S's P/E ratio is -11.92. In terms of profitability, HCP's ROE is -0.16%, compared to S's ROE of -0.30%. Regarding short-term risk, HCP is less volatile compared to S. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check S's competition here
HCP vs KLAR Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, KLAR has a market cap of 5.4B. Regarding current trading prices, HCP is priced at $34.78, while KLAR trades at $14.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas KLAR's P/E ratio is -18.22. In terms of profitability, HCP's ROE is -0.16%, compared to KLAR's ROE of -0.12%. Regarding short-term risk, HCP is less volatile compared to KLAR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KLAR's competition here
HCP vs CORZW Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZW has a market cap of 5.1B. Regarding current trading prices, HCP is priced at $34.78, while CORZW trades at $16.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CORZW's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to CORZW's ROE of +1.09%. Regarding short-term risk, HCP is less volatile compared to CORZW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZW's competition here
HCP vs RELY Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, RELY has a market cap of 5.1B. Regarding current trading prices, HCP is priced at $34.78, while RELY trades at $24.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas RELY's P/E ratio is 50.58. In terms of profitability, HCP's ROE is -0.16%, compared to RELY's ROE of +0.13%. Regarding short-term risk, HCP is less volatile compared to RELY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RELY's competition here
HCP vs WEX Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, WEX has a market cap of 4.9B. Regarding current trading prices, HCP is priced at $34.78, while WEX trades at $140.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas WEX's P/E ratio is 15.83. In terms of profitability, HCP's ROE is -0.16%, compared to WEX's ROE of +0.27%. Regarding short-term risk, HCP is less volatile compared to WEX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WEX's competition here
HCP vs NVEI Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, HCP is priced at $34.78, while NVEI trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NVEI's P/E ratio is 212.44. In terms of profitability, HCP's ROE is -0.16%, compared to NVEI's ROE of -0.00%. Regarding short-term risk, HCP is more volatile compared to NVEI. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check NVEI's competition here
HCP vs KVYO Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, KVYO has a market cap of 4.7B. Regarding current trading prices, HCP is priced at $34.78, while KVYO trades at $15.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas KVYO's P/E ratio is -518.00. In terms of profitability, HCP's ROE is -0.16%, compared to KVYO's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to KVYO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KVYO's competition here
HCP vs WIX Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, WIX has a market cap of 4.4B. Regarding current trading prices, HCP is priced at $34.78, while WIX trades at $79.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas WIX's P/E ratio is 90.13. In terms of profitability, HCP's ROE is -0.16%, compared to WIX's ROE of -0.22%. Regarding short-term risk, HCP is less volatile compared to WIX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WIX's competition here
HCP vs ACIW Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ACIW has a market cap of 4.3B. Regarding current trading prices, HCP is priced at $34.78, while ACIW trades at $42.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ACIW's P/E ratio is 21.39. In terms of profitability, HCP's ROE is -0.16%, compared to ACIW's ROE of +0.14%. Regarding short-term risk, HCP is less volatile compared to ACIW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ACIW's competition here
HCP vs ESMT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, HCP is priced at $34.78, while ESMT trades at $23.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ESMT's P/E ratio is 153.67. In terms of profitability, HCP's ROE is -0.16%, compared to ESMT's ROE of +0.03%. Regarding short-term risk, HCP is less volatile compared to ESMT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ESMT's competition here
HCP vs DLO Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, DLO has a market cap of 3.9B. Regarding current trading prices, HCP is priced at $34.78, while DLO trades at $13.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas DLO's P/E ratio is 20.40. In terms of profitability, HCP's ROE is -0.16%, compared to DLO's ROE of +0.38%. Regarding short-term risk, HCP is less volatile compared to DLO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DLO's competition here
HCP vs FOUR Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FOUR has a market cap of 3.8B. Regarding current trading prices, HCP is priced at $34.78, while FOUR trades at $41.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FOUR's P/E ratio is 47.68. In terms of profitability, HCP's ROE is -0.16%, compared to FOUR's ROE of +0.06%. Regarding short-term risk, HCP is less volatile compared to FOUR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FOUR's competition here
HCP vs BB Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, BB has a market cap of 3.7B. Regarding current trading prices, HCP is priced at $34.78, while BB trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas BB's P/E ratio is 69.06. In terms of profitability, HCP's ROE is -0.16%, compared to BB's ROE of +0.07%. Regarding short-term risk, HCP is less volatile compared to BB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BB's competition here
HCP vs BOX Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, BOX has a market cap of 3.4B. Regarding current trading prices, HCP is priced at $34.78, while BOX trades at $24.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas BOX's P/E ratio is 42.26. In terms of profitability, HCP's ROE is -0.16%, compared to BOX's ROE of +1.16%. Regarding short-term risk, HCP is less volatile compared to BOX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BOX's competition here
HCP vs VRNS Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, VRNS has a market cap of 3.3B. Regarding current trading prices, HCP is priced at $34.78, while VRNS trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas VRNS's P/E ratio is -24.78. In terms of profitability, HCP's ROE is -0.16%, compared to VRNS's ROE of -0.26%. Regarding short-term risk, HCP is less volatile compared to VRNS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VRNS's competition here
HCP vs CLBT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CLBT has a market cap of 3.3B. Regarding current trading prices, HCP is priced at $34.78, while CLBT trades at $13.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CLBT's P/E ratio is 42.10. In terms of profitability, HCP's ROE is -0.16%, compared to CLBT's ROE of +0.18%. Regarding short-term risk, HCP is less volatile compared to CLBT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CLBT's competition here
HCP vs QLYS Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, QLYS has a market cap of 3.2B. Regarding current trading prices, HCP is priced at $34.78, while QLYS trades at $91.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas QLYS's P/E ratio is 16.43. In terms of profitability, HCP's ROE is -0.16%, compared to QLYS's ROE of +0.37%. Regarding short-term risk, HCP is less volatile compared to QLYS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check QLYS's competition here
HCP vs SWI Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, HCP is priced at $34.78, while SWI trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SWI's P/E ratio is 28.89. In terms of profitability, HCP's ROE is -0.16%, compared to SWI's ROE of +0.08%. Regarding short-term risk, HCP is more volatile compared to SWI. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SWI's competition here
HCP vs TDC Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, TDC has a market cap of 3B. Regarding current trading prices, HCP is priced at $34.78, while TDC trades at $32.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas TDC's P/E ratio is 7.39. In terms of profitability, HCP's ROE is -0.16%, compared to TDC's ROE of +1.42%. Regarding short-term risk, HCP is less volatile compared to TDC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TDC's competition here
HCP vs EVOP Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, HCP is priced at $34.78, while EVOP trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas EVOP's P/E ratio is -309.00. In terms of profitability, HCP's ROE is -0.16%, compared to EVOP's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to EVOP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVOP's competition here
HCP vs NTCT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, NTCT has a market cap of 2.9B. Regarding current trading prices, HCP is priced at $34.78, while NTCT trades at $40.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas NTCT's P/E ratio is 31.28. In terms of profitability, HCP's ROE is -0.16%, compared to NTCT's ROE of +0.06%. Regarding short-term risk, HCP is less volatile compared to NTCT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NTCT's competition here
HCP vs PAGS Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PAGS has a market cap of 2.9B. Regarding current trading prices, HCP is priced at $34.78, while PAGS trades at $9.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PAGS's P/E ratio is 6.77. In terms of profitability, HCP's ROE is -0.16%, compared to PAGS's ROE of +0.14%. Regarding short-term risk, HCP is less volatile compared to PAGS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAGS's competition here
HCP vs CCC Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CCC has a market cap of 2.9B. Regarding current trading prices, HCP is priced at $34.78, while CCC trades at $4.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CCC's P/E ratio is 81.33. In terms of profitability, HCP's ROE is -0.16%, compared to CCC's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to CCC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CCC's competition here
HCP vs STNE Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, STNE has a market cap of 2.8B. Regarding current trading prices, HCP is priced at $34.78, while STNE trades at $10.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas STNE's P/E ratio is 5.95. In terms of profitability, HCP's ROE is -0.16%, compared to STNE's ROE of +0.20%. Regarding short-term risk, HCP is less volatile compared to STNE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check STNE's competition here
HCP vs EEFT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, EEFT has a market cap of 2.6B. Regarding current trading prices, HCP is priced at $34.78, while EEFT trades at $69.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas EEFT's P/E ratio is 10.21. In terms of profitability, HCP's ROE is -0.16%, compared to EEFT's ROE of +0.24%. Regarding short-term risk, HCP is less volatile compared to EEFT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EEFT's competition here
HCP vs WRD Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, WRD has a market cap of 2.5B. Regarding current trading prices, HCP is priced at $34.78, while WRD trades at $7.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas WRD's P/E ratio is -9.82. In terms of profitability, HCP's ROE is -0.16%, compared to WRD's ROE of -0.24%. Regarding short-term risk, HCP is less volatile compared to WRD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WRD's competition here
HCP vs TENB Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, TENB has a market cap of 2.3B. Regarding current trading prices, HCP is priced at $34.78, while TENB trades at $21.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas TENB's P/E ratio is -213.10. In terms of profitability, HCP's ROE is -0.16%, compared to TENB's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to TENB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TENB's competition here
HCP vs CSGS Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, CSGS has a market cap of 2.3B. Regarding current trading prices, HCP is priced at $34.78, while CSGS trades at $80.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas CSGS's P/E ratio is 35.87. In terms of profitability, HCP's ROE is -0.16%, compared to CSGS's ROE of +0.22%. Regarding short-term risk, HCP is less volatile compared to CSGS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CSGS's competition here
HCP vs AVPT Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, AVPT has a market cap of 2.2B. Regarding current trading prices, HCP is priced at $34.78, while AVPT trades at $10.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas AVPT's P/E ratio is 52.35. In terms of profitability, HCP's ROE is -0.16%, compared to AVPT's ROE of +0.10%. Regarding short-term risk, HCP is less volatile compared to AVPT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AVPT's competition here
HCP vs AVDX Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, AVDX has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while AVDX trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas AVDX's P/E ratio is -250.00. In terms of profitability, HCP's ROE is -0.16%, compared to AVDX's ROE of -0.02%. Regarding short-term risk, HCP is more volatile compared to AVDX. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check AVDX's competition here
HCP vs GETVV Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while GETVV trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GETVV's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.16%, compared to GETVV's ROE of N/A. Regarding short-term risk, HCP is less volatile compared to GETVV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GETVV's competition here
HCP vs ATEN Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ATEN has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while ATEN trades at $28.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ATEN's P/E ratio is 45.92. In terms of profitability, HCP's ROE is -0.16%, compared to ATEN's ROE of +0.21%. Regarding short-term risk, HCP is less volatile compared to ATEN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ATEN's competition here
HCP vs FORG Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FORG has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while FORG trades at $23.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FORG's P/E ratio is -22.53. In terms of profitability, HCP's ROE is -0.16%, compared to FORG's ROE of -0.20%. Regarding short-term risk, HCP is less volatile compared to FORG. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FORG's competition here
HCP vs EVCM Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, EVCM has a market cap of 1.9B. Regarding current trading prices, HCP is priced at $34.78, while EVCM trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas EVCM's P/E ratio is 84.62. In terms of profitability, HCP's ROE is -0.16%, compared to EVCM's ROE of +0.04%. Regarding short-term risk, HCP is less volatile compared to EVCM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVCM's competition here
HCP vs SPSC Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SPSC has a market cap of 1.9B. Regarding current trading prices, HCP is priced at $34.78, while SPSC trades at $52.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SPSC's P/E ratio is 21.90. In terms of profitability, HCP's ROE is -0.16%, compared to SPSC's ROE of +0.09%. Regarding short-term risk, HCP is less volatile compared to SPSC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SPSC's competition here
HCP vs GSKY Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, HCP is priced at $34.78, while GSKY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GSKY's P/E ratio is 18.61. In terms of profitability, HCP's ROE is -0.16%, compared to GSKY's ROE of +5.47%. Regarding short-term risk, HCP is less volatile compared to GSKY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GSKY's competition here
HCP vs RAMP Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, RAMP has a market cap of 1.9B. Regarding current trading prices, HCP is priced at $34.78, while RAMP trades at $29.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas RAMP's P/E ratio is 28.21. In terms of profitability, HCP's ROE is -0.16%, compared to RAMP's ROE of +0.07%. Regarding short-term risk, HCP is less volatile compared to RAMP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RAMP's competition here
HCP vs GET Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, HCP is priced at $34.78, while GET trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas GET's P/E ratio is 31.33. In terms of profitability, HCP's ROE is -0.16%, compared to GET's ROE of N/A. Regarding short-term risk, HCP is less volatile compared to GET. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GET's competition here
HCP vs MQ Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, MQ has a market cap of 1.7B. Regarding current trading prices, HCP is priced at $34.78, while MQ trades at $4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas MQ's P/E ratio is 405.50. In terms of profitability, HCP's ROE is -0.16%, compared to MQ's ROE of +0.00%. Regarding short-term risk, HCP is less volatile compared to MQ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MQ's competition here
HCP vs PAYO Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PAYO has a market cap of 1.7B. Regarding current trading prices, HCP is priced at $34.78, while PAYO trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PAYO's P/E ratio is 25.55. In terms of profitability, HCP's ROE is -0.16%, compared to PAYO's ROE of +0.10%. Regarding short-term risk, HCP is less volatile compared to PAYO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAYO's competition here
HCP vs STER Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while STER trades at $16.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas STER's P/E ratio is -98.47. In terms of profitability, HCP's ROE is -0.16%, compared to STER's ROE of -0.00%. Regarding short-term risk, HCP is less volatile compared to STER. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check STER's competition here
HCP vs FIVN Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, FIVN has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while FIVN trades at $21.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas FIVN's P/E ratio is 32.94. In terms of profitability, HCP's ROE is -0.16%, compared to FIVN's ROE of +0.07%. Regarding short-term risk, HCP is less volatile compared to FIVN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FIVN's competition here
HCP vs BAND Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, BAND has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while BAND trades at $49.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas BAND's P/E ratio is -131.45. In terms of profitability, HCP's ROE is -0.16%, compared to BAND's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to BAND. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BAND's competition here
HCP vs ZUO Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while ZUO trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas ZUO's P/E ratio is -19.65. In terms of profitability, HCP's ROE is -0.16%, compared to ZUO's ROE of -0.44%. Regarding short-term risk, HCP is less volatile compared to ZUO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ZUO's competition here
HCP vs PICS Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, PICS has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while PICS trades at $11.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas PICS's P/E ratio is 6.98. In terms of profitability, HCP's ROE is -0.16%, compared to PICS's ROE of +0.16%. Regarding short-term risk, HCP is less volatile compared to PICS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PICS's competition here
HCP vs APPN Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, APPN has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while APPN trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas APPN's P/E ratio is 1026.50. In terms of profitability, HCP's ROE is -0.16%, compared to APPN's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to APPN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check APPN's competition here
HCP vs TUYA Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, TUYA has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while TUYA trades at $2.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas TUYA's P/E ratio is 27.50. In terms of profitability, HCP's ROE is -0.16%, compared to TUYA's ROE of +0.06%. Regarding short-term risk, HCP is less volatile compared to TUYA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TUYA's competition here
HCP vs SUMO Comparison May 2026
HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCP stands at 7.1B. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while SUMO trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCP currently has a P/E ratio of -57.97, whereas SUMO's P/E ratio is -11.36. In terms of profitability, HCP's ROE is -0.16%, compared to SUMO's ROE of -0.31%. Regarding short-term risk, HCP is more volatile compared to SUMO. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SUMO's competition here